CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
Clinical trial NCT03798678 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03798678
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-08
- Primary completion
- 2023-11-07
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.